BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38470175)

  • 1. Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism.
    Wiltrout K; Brimble E; Poduri A
    Epilepsia; 2024 May; 65(5):1428-1438. PubMed ID: 38470175
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Vlaskamp DRM; Shaw BJ; Burgess R; Mei D; Montomoli M; Xie H; Myers CT; Bennett MF; XiangWei W; Williams D; Maas SM; Brooks AS; Mancini GMS; van de Laar IMBH; van Hagen JM; Ware TL; Webster RI; Malone S; Berkovic SF; Kalnins RM; Sicca F; Korenke GC; van Ravenswaaij-Arts CMA; Hildebrand MS; Mefford HC; Jiang Y; Guerrini R; Scheffer IE
    Neurology; 2019 Jan; 92(2):e96-e107. PubMed ID: 30541864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression.
    Jimenez-Gomez A; Niu S; Andujar-Perez F; McQuade EA; Balasa A; Huss D; Coorg R; Quach M; Vinson S; Risen S; Holder JL
    J Neurodev Disord; 2019 Aug; 11(1):18. PubMed ID: 31395010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.
    Berryer MH; Hamdan FF; Klitten LL; Møller RS; Carmant L; Schwartzentruber J; Patry L; Dobrzeniecka S; Rochefort D; Neugnot-Cerioli M; Lacaille JC; Niu Z; Eng CM; Yang Y; Palardy S; Belhumeur C; Rouleau GA; Tommerup N; Immken L; Beauchamp MH; Patel GS; Majewski J; Tarnopolsky MA; Scheffzek K; Hjalgrim H; Michaud JL; Di Cristo G
    Hum Mutat; 2013 Feb; 34(2):385-94. PubMed ID: 23161826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an individual with a SYGNAP1 pathogenic mutation in India.
    Verma V; Mandora A; Botre A; Clement JP
    Mol Biol Rep; 2020 Nov; 47(11):9225-9234. PubMed ID: 33090308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of early neurodevelopmental features of children with SYNGAP1 variants and their genotypes].
    Liu H; Yang S; Li J; Xie H; Chen X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jan; 41(1):25-31. PubMed ID: 38171555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploratory study of sleep quality and quantity in children with causal variants in SYNGAP1, an autism risk gene.
    Paasch V; Doucoure A; Bifano M; Smith-Hicks CL
    Sleep Med; 2023 Jul; 107():101-107. PubMed ID: 37146502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum.
    Smith L; Singhal N; El Achkar CM; Truglio G; Rosen Sheidley B; Sullivan J; Poduri A
    Epilepsia; 2018 Mar; 59(3):679-689. PubMed ID: 29377098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
    Parker MJ; Fryer AE; Shears DJ; Lachlan KL; McKee SA; Magee AC; Mohammed S; Vasudevan PC; Park SM; Benoit V; Lederer D; Maystadt I; Study D; FitzPatrick DR
    Am J Med Genet A; 2015 Oct; 167A(10):2231-7. PubMed ID: 26079862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.
    Prchalova D; Havlovicova M; Sterbova K; Stranecky V; Hancarova M; Sedlacek Z
    BMC Med Genet; 2017 Jun; 18(1):62. PubMed ID: 28576131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-parametric analysis of 57 SYNGAP1 variants reveal impacts on GTPase signaling, localization, and protein stability.
    Meili F; Wei WJ; Sin WC; Meyers WM; Dascalu I; Callaghan DB; Rogic S; Pavlidis P; Haas K
    Am J Hum Genet; 2021 Jan; 108(1):148-162. PubMed ID: 33308442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy.
    Mignot C; von Stülpnagel C; Nava C; Ville D; Sanlaville D; Lesca G; Rastetter A; Gachet B; Marie Y; Korenke GC; Borggraefe I; Hoffmann-Zacharska D; Szczepanik E; Rudzka-Dybała M; Yiş U; Çağlayan H; Isapof A; Marey I; Panagiotakaki E; Korff C; Rossier E; Riess A; Beck-Woedl S; Rauch A; Zweier C; Hoyer J; Reis A; Mironov M; Bobylova M; Mukhin K; Hernandez-Hernandez L; Maher B; Sisodiya S; Kuhn M; Glaeser D; Weckhuysen S; Myers CT; Mefford HC; Hörtnagel K; Biskup S; ; Lemke JR; Héron D; Kluger G; Depienne C
    J Med Genet; 2016 Aug; 53(8):511-22. PubMed ID: 26989088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description.
    Wright D; Kenny A; Eley S; McKechanie AG; Stanfield AC
    J Neurodev Disord; 2022 Jun; 14(1):34. PubMed ID: 35655128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and phenotypical findings of a novel de novo SYNGAP1 gene variant in an 11-year-old Iranian boy with intellectual disability.
    Mir A; Song Y; Lee H; Nadeali Z; Akbarian F; Tabatabaiefar MA
    Lab Med; 2024 Mar; 55(2):204-208. PubMed ID: 37467311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chewing induced reflex seizures ("eating epilepsy") and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: Review of literature and report of 8 cases.
    von Stülpnagel C; Hartlieb T; Borggräfe I; Coppola A; Gennaro E; Eschermann K; Kiwull L; Kluger F; Krois I; Møller RS; Rössler F; Santulli L; Schwermer C; Wallacher-Scholz B; Zara F; Wolf P; Kluger G
    Seizure; 2019 Feb; 65():131-137. PubMed ID: 30685520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and gene analysis of SYNGAP1-related epilepsy in children].
    Tian XJ; Fang F; Ding CH; Ren XT; Wang X; Wang XF; Lyu JL; Jin H; Han TL; Deng J
    Zhonghua Er Ke Za Zhi; 2021 Dec; 59(12):1059-1064. PubMed ID: 34856666
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenotypic and genetic spectrum of epilepsy with myoclonic atonic seizures.
    Tang S; Addis L; Smith A; Topp SD; Pendziwiat M; Mei D; Parker A; Agrawal S; Hughes E; Lascelles K; Williams RE; Fallon P; Robinson R; Cross HJ; Hedderly T; Eltze C; Kerr T; Desurkar A; Hussain N; Kinali M; Bagnasco I; Vassallo G; Whitehouse W; Goyal S; Absoud M; ; Møller RS; Helbig I; Weber YG; Marini C; Guerrini R; Simpson MA; Pal DK
    Epilepsia; 2020 May; 61(5):995-1007. PubMed ID: 32469098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulators.
    Weldon M; Kilinc M; Lloyd Holder J; Rumbaugh G
    J Neurodev Disord; 2018 Feb; 10(1):6. PubMed ID: 29402231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo variants in CACNA1E found in patients with intellectual disability, developmental regression and social cognition deficit but no seizures.
    Royer-Bertrand B; Jequier Gygax M; Cisarova K; Rosenfeld JA; Bassetti JA; Moldovan O; O'Heir E; Burrage LC; Allen J; Emrick LT; Eastman E; Kumps C; Abbas S; Van Winckel G; ; Chabane N; Zackai EH; Lebon S; Keena B; Bhoj EJ; Umair M; Li D; Donald KA; Superti-Furga A
    Mol Autism; 2021 Oct; 12(1):69. PubMed ID: 34702355
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.